SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-013184
Filing Date
2020-03-26
Accepted
2020-03-26 16:01:19
Documents
3
Period of Report
2020-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vir-8k_20200326.htm 8-K 28791
2 EX-99.1 vir-ex991_7.htm EX-99.1 329081
3 GRAPHIC gnvyk3b3spbk000001.jpg GRAPHIC 5807
  Complete submission text file 0001564590-20-013184.txt   367180
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 20746125
SIC: 2836 Biological Products, (No Diagnostic Substances)